SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-010033 to BELDEN INC. (BDC) (CIK 0000913142) (BDC)

BELDEN INC. (BDC) (CIK 0000913142)
Date: Sept. 5, 2024 · CIK: 0000913142 · Accession: 0000000000-24-010033

AI Filing Summary & Sentiment

File numbers found in text: 001-12561

Date
September 5, 2024
Author
Not clearly detected
Form
UPLOAD
Company
BELDEN INC. (BDC) (CIK 0000913142)

Letter

September 5, 2024 Ashish Chand President and Chief Executive Officer Belden Inc. 1 North Brentwood Boulevard 15th Floor St. Louis, MO 63105 Re:Belden Inc. Definitive Proxy Statement on Schedule 14A Filed April 9, 2024 File No. 001-12561 Dear Ashish Chand: We have limited our review of your most recent definitive proxy statement to those issues we have addressed in our comment(s). Please respond to this letter by providing the requested information and/or confirming that you will revise your future proxy disclosures in accordance with the topics discussed below . If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Definitive Proxy Statement on Schedule 14A Pay Versus Performance, page 30 1.Refer to your tabular columns showing compensation actually paid amounts for PEOs Chand, Vestjens and Roel. Since Dr. Chand and Messrs. Vestjens and Stroup were all “PEO”s, as defined in Item 402(a)(3) of Regulation S-K, please revise future filings to use the term PEO in these column headings, rather than “NEO.” Note that Item 402(v) of Regulation S-K contemplates separate disclosure for the PEO and the non-PEO named executive officers. Refer to the second, third and fourth columns in your pay versus performance table, which include Summary Compensation Table totals for the three PEOs. Although these columns appear to include the same category of information, only the third and fourth column headings include the “(b)” designation. The same presentation appears in the fifth, sixth and seventh column headings with a “(c)” designation appearing only in the fifth and sixth 2.

September 5, 2024 Page 2 column headings. Please tell us the distinction, if any, between the categories of data in these columns and revise future filings as applicable. 3.We note that you have included “Adjusted Earnings Per Share,” a non-GAAP measure, as your Company-Selected Measure pursuant to Item 402(v)(2)(vi) of Regulation S-K. While Company-Selected Measure disclosure is not subject to Regulation G or Item 10(e) of Regulation S-K, you must disclose how the measure is calculated from your audited financial statements. Please tell us and revise future disclosure to explain how this number is calculated from your audited financial statements. If the disclosure appears in a different part of the definitive proxy statement, you may satisfy the disclosure requirement by a cross-reference thereto. We note that you refer in footnote (5) to your 2023 Annual Report on Form 10-K, filed on February 8, 2024, for a presentation of your Company-Selected Measure. We are unable, however, to locate any “Adjusted Earnings Per Share” disclosure in that filing. In addition, incorporation by reference to a separate filing will not satisfy the Item 402(v)(2)(vi) of Regulation S-K requirement to disclose how the Company-Selected Measure is calculated from your audited financial statements. 4.Refer to footnote (6) to your pay versus performance table where you disclose a change in the “Compensation Actually Received” amounts for 2022. Please tell us whether “Compensation Actually Received” is calculated differently from compensation actually paid and if so, explain how the difference relates to or is derived from the referenced “SEC Guidance released in November of 2023.” 5.We note the graph titled “Compensation Actually Paid v. Net Income” on page 33. Please ensure the data point representing net income for 2020 aligns with the appropriate value for the 2020 net income as reported in your pay versus performance table. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Charlotte Young at 202-551-3280 or Amanda Ravitz at 202-551-3412 with any questions. Sincerely, Division of Corporation Finance Disclosure Review Program

Show Raw Text
September 5, 2024
Ashish Chand
President and Chief Executive Officer
Belden Inc.
1 North Brentwood Boulevard
15th Floor
St. Louis, MO 63105
Re:Belden Inc.
Definitive Proxy Statement on Schedule 14A
Filed April 9, 2024
File No. 001-12561
Dear Ashish Chand:
            We have limited our review of your most recent definitive proxy statement to those issues
we have addressed in our comment(s).
            Please respond to this letter by providing the requested information  and/or confirming that
you will revise your future proxy disclosures in accordance with  the topics discussed below . If
you do not believe a comment applies to your facts and circumstances, please tell us why in your
response.
            After reviewing your response to this letter, we may have additional  comments.
Definitive Proxy Statement on Schedule 14A
Pay Versus Performance, page 30
1.Refer to your tabular columns showing compensation actually paid amounts for
PEOs Chand, Vestjens and Roel. Since Dr. Chand and Messrs. Vestjens and Stroup were
all “PEO”s, as defined in Item 402(a)(3) of Regulation S-K, please revise future filings to
use the term PEO in these column headings, rather than “NEO.” Note that Item 402(v) of
Regulation S-K contemplates separate disclosure for the PEO and the non-PEO named
executive officers.
Refer to the second, third and fourth columns in your pay versus performance table, which
include Summary Compensation Table totals for the three PEOs. Although these columns
appear to include the same category of information, only the third and fourth column
headings include the “(b)” designation. The same presentation appears in the fifth, sixth
and seventh column headings with a “(c)” designation appearing only in the fifth and sixth 2.

September 5, 2024
Page 2
column headings. Please tell us the distinction, if any, between the categories of data in
these columns and revise future filings as applicable.
3.We note that you have included “Adjusted Earnings Per Share,” a non-GAAP measure, as
your Company-Selected Measure pursuant to Item 402(v)(2)(vi) of Regulation S-K.
While Company-Selected Measure disclosure is not subject to Regulation G or Item 10(e)
of Regulation S-K, you must disclose how the measure is calculated from your audited
financial statements. Please tell us and revise future disclosure to explain how this number
is calculated from your audited financial statements. If the disclosure appears in a
different part of the definitive proxy statement, you may satisfy the disclosure
requirement by a cross-reference thereto. We note that you refer in footnote (5) to your
2023 Annual Report on Form 10-K, filed on February 8, 2024, for a presentation of your
Company-Selected Measure. We are unable, however, to locate any “Adjusted Earnings
Per Share” disclosure in that filing. In addition, incorporation by reference to a separate
filing will not satisfy the Item 402(v)(2)(vi) of Regulation S-K requirement to disclose
how the Company-Selected Measure is calculated from your audited financial statements.
4.Refer to footnote (6) to your pay versus performance table where you disclose a change in
the “Compensation Actually Received” amounts for 2022. Please tell us whether
“Compensation Actually Received” is calculated differently from compensation actually
paid and if so, explain how the difference relates to or is derived from the referenced
“SEC Guidance released in November of 2023.”
5.We note the graph titled “Compensation Actually Paid v. Net Income” on page 33. Please
ensure the data point representing net income for 2020 aligns with the appropriate value
for the 2020 net income as reported in your pay versus performance table.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Please contact Charlotte Young at 202-551-3280 or Amanda Ravitz at 202-551-3412 with
any questions.
Sincerely,
Division of Corporation Finance
Disclosure Review Program